Table 1. Basic demographics of the studied subjects.
| Patient characteristics | SHF (n = 74) | HFpEF (n = 65) | non-HF (n = 61) |
|---|---|---|---|
| Age, year | 64.0 (55.0~71.3)* | 71.0 (60.0~77.5) | 65.0 (60.0~71.5) |
| Gender (male), % | 83.8*,† | 46.2 | 45.9 |
| BMI, kg/m2 | 24.6 (22.6~26.9)† | 25.7 (22.4~28.9) | 26.5 (25.0~29.6) |
| BSA, m2 | 1.74 (1.65~1.88) | 1.67 (1.59~1.82) | 1.73 (1.62~1.81) |
| Comorbidities | |||
| HTN, % | 82.4 | 83.1 | 85.2 |
| DM, % | 21.6 | 36.9 | 27.9 |
| Dyslipidemia, % | 45.9 | 38.5 | 52.5 |
| CKD, % | 9.5 | 9.2 | 1.6 |
| Stroke, % | 5.4 | 4.6 | 1.6 |
| MI, % | 25.7† | 18.5† | 4.9 |
| CAD | 50.0 | 40.0 | 44.3 |
| PAOD, % | 2.7 | 3.1 | 3.3 |
| Valvular heart disease | 4.1 | 3.1 | 1.6 |
| Medications | |||
| ACEI | 4.1 | 1.5 | 1.6 |
| ARB | 58.1 | 63.1 | 63.9 |
| Beta-blocker | 71.6*,† | 47.7 | 49.2 |
Abbreviations: SHF, systolic heart failure; HFpEF, heart failure with preserved ejection fraction; non-HF, patients without heart failure; BMI, body mass index; BSA, body surface area; HTN, hypertension; DM, diabetes mellitus; CKD, chronic kidney disease; MI, myocardial infarction; CAD, coronary artery disease; PAOD, peripheral arterial occlusive disease; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker.
*p < 0.05 compared with HFpEF.
†p < 0.05 compared with the non-HF group.